Indication for repeat surgery of glioblastoma: Influence of progress of disease

Frontiers of Radiation Therapy and Oncology

Volumn 33, Issue , 1999, Pages 192-201

  Muhling M ^a,b   Krage, J ^a   Hussein, S ^a   Samii, M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Gesundheitszentrum St Martin GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; BRAIN TUMOR; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATION; REOPERATION; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL; TUMOR RECURRENCE;

ABO BLOOD-GROUP SYSTEM; ADULT; AGE DISTRIBUTION; AGED; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; REOPERATION; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 0032623359     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (60)

1. Apuzzo MLJ, Mitchell MS: Immunological aspects of intrinsic glial tumors. J Neurosurg 1981;55:1-18.
2. Bashir R, Hochberg FH, Linggood R, Hottleman K: Preirradiation internal carotid artery BCNU in treatment of glioblastoma multiforme. J Neurosurg 1988;68:917-919.
3. Berger MS, Tucker BA, Spence A, Winn HR: Reoperation for glioma. Clin Neurosurg 1992;39:172-186.
4. Bosnes V, Hirschberg H: Comparison of in vitro glioma cell cytotoxicity of LAK cells from glioma patients and healthy subjects. J Neurosurg 1988;69:234-238.
5. Brooks WH, Caldwell HD, Mortara RH: Immune responses in patients with gliomas. Surg Neurol 1974;2:419-423.
6. Bucy PC: Glioblastomas. Surg Neurol 1985;24:589-590.
7. Burger PC, Dubois PJ, Schold SC: Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 1983;58:159-169.
8. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987;59:1617-1625.
9. Burger PC, Vogel FS, Green SB, et al: Glioblastoma multiforme and anaplastic astrocytoma. Cancer 1985;56:1106-1111.
10. Chandler KL, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993;32:716-720.
11. Chang CH, Horton J, Schoenfeod D: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983;52:997-1007.
12. DeVita VT Jr: The relationship between tumor mass and resistance to chemotherapy. Cancer 1983;51:1209-1220.
13. Diemath HE: The course or glioblastoma multiforme. Neurochirurgia 1960;3:45-59.
14. Forsting M, Albert FK, Kunze S, et al: Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. Am J Neuroradiol 1993;14:77-87.
15. Fusek I, Vorreith M: Indications for repeat surgery of brain gliomas. Zentralbl Neurochir 1976;37:45-50.
16. Harsh GR IV, Levin VA, Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987;21:615-621.
17. Heppner F: The glioblastoma multiforme: A lifelong challenge to the neurosurgeon. Neurochirurgia 1986;29:9-14.
18. Hoshino T: A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 1984;61:895-900.
19. Hoshino T, Barker M, Wilson CB: Cell kinetics of human gliomas. J Neurosurg 1972;37:15-26.
20. Hoshino T, Wilson CB, Rosenblum ML, Barker M: Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas. J Neurosurg 1975;43:127-135.
21. Jellinger K: Glioblastoma multiforme: Morphology and biology. Acta Neurochir 1978;42:5-32.
22. Jellinger K, Volc D, Grisold W, et al: Multimodality treatment of malignant gliomas - Comparison of several adjuvant approaches. Zentralbl Neurochir 1981;42:99-122.
23. Jelsma R, Bucy PC: Glioblastoma multiforme: Its treatment and some factors effecting survival. Arch Neurol 1969;20:161-171.
24. Kornblith PK, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 1988;68:1-17.
25. Kornblith PK, Welch WC, Bradley MK: The future of therapy for glioblastoma. Surg Neurol 1993;39:538-543.
26. Kothe W, Richter HH: Prognosis and therapy of glioblastoma multiforme. Psychiatr Neurol Med Psychol 1963;15:276-282.
27. Krause G, Zülch KJ: Prevalence of brain gliomas in different regions of the brain. Zentralbl Neurochir 1951;11:221-230.
28. Krayenbühl H: Anamnesis and clinical course of glioblastoma multiforme. Acta Neurochir 1959;6:31-39.
29. Kreth FW, Berlis A, Scheremet R, Ostertag CB: Heterogeneous treatment effects after surgery and/or radiotherapy of glioblastoma multiforme. Zentralbl Neurochir 1996;suppl 43.
30. Kreth FW, Warnke PC, Scheremet R, Ostertag CB: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 1993;78:762-766.
31. Kuppner MC, Hamou MF, de Tribolet N: Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas. J Neuroimmunol 1990;29:229-238.
32. Landy HJ, Feun L, Schwade JG, et al: Retreatment of intracranial gliomas. South Med J 1994;87:2.
33. Leibel SA, Sheline GE: Radiation therapy for neoplasms of the brain. J Neurosurg 1987;66:1-22.
34. Levin VA, Crafts DC, Norman DM, et al: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 1977;47:329-335.
35. Mahaley MS: Immunotherapy of brain tumors - Is there a future? Clin Neurosurg 1977;25:382-387.
36. Mahaley MS, Brooks WH, Roszman TL, et al: Immunobiology of primary intracranial tumors. J Neurosurg 1977;46:467-472.
37. McLendon RE, Robinson JS, Chambers DB, et al: The glioblastoma multiforme in Georgia, 1977-1981. Cancer 1985;56:894-897.
38. Müller H, Brock M, Ernst H: Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas. Clin Neurol Neurosurg 1985;87:167-171.
39. Neumann J: Actual prognosis of glioblastoma multiforme. Nervenarzt 1983;54:191-193.
40. Ramsey RG, Brand WN: Radiotherapy of glioblastoma multiforme. J Neurosurg 1973;39:197-202.
41. Ransohoff J, Lieberman A: Surgical therapy of primary malignant brain tumors. Clin Neurosurg 1978;25:403-411.
42. Ray BS: Surgery of recurrent intracranial tumors. Clin Neurosurg 1964;10:1-30.
43. Reeves GI, Marks JE: Prognostic significance of lesion size for glioblastoma multiforme. Radiology 1979;132:469-471.
44. Salcman M: Specialty rounds: Glioblastoma multiforme. Am J Med Sci 1980;279:84-94.
45. Salcman M: Survival in glioblastoma: Historical perspective. Neurosurgery 1980;7:435-439.
46. Salcman M, Kaplan RS, Ducker TB, et al: Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery 1982;10:454-462.
47. Selby R: The surgical treatment of cerebral glioblastoma multiforme: A historical review. J Neurooncol 1994;18:175-182.
48. Strömblad LG, Anderson H, Malmström P, Saford LG: Reoperation for malignant astrocytomas: Personal experience and a review of the literature. Br J Neurosurg 1993;7:623-633.
49. Taveras JM, Thompson HG Jr, Pool JL: Should we treat glioblastoma multiforme? AJR 1962;87:473-479.
50. Tönnis W, Walter W: Glioblastoma multiforme. Acta Neurochir 1959;6:40-61.
51. Trouillas P, Lapras C: Immunothé rapie active des tumeurs cé rébrales. Neurochirurgie 1970;16:143-170.
52. Ushio Y, Hayakawa T, Hasegawa H, Yamada K, Arita N: Chemotherapy of malignant gliomas. Neurosurg Rev 1984;7:3-12.
53. Wallner KE, Galicich JH, Malkin MG, et al: Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation. J Clin Oncol 1989;7:1492-1496.
54. Weir B: The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4. J Neurosurg 1973;38:448-452.
55. Wilson CB: Glioblastoma: The past, the present, and the future. Clin Neurosurg 1992;38:32-48.
56. Wilson CB, Hoshino T: Current trends in the chemotherapy of brain tumors with special reference to glioblastomas. J Neurosurg 1969;31:589-603.
57. Yasuda K, Alderson T, Phillips J, Sikora K: Detection of lymphocytes in malignant gliomas by monoclonal antibodies. J Neurol Neurosurg Psychiatr 1983;46:734-737.
58. Young B, Oldfield EH, Markesbery WR, et al: Reoperation for glioblastoma. J Neurosurg 1981;15:917-921.
59. Young HF, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumor. Surg Neurol 1976;5:19-23.
60. Zülch KJ: Glioblastoma multiforme: Morphology and biology. Acta Neurochir 1959;6:2-29.